| 1 | [SID125305911] | Inactive | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID125305911] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID125305911] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID125305911] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID125305911] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID125305911] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID125305911] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID125305911] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID125305911] | Inactive | Potency | | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 10 | [SID125305911] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 11 | [SID125305911] | Inactive | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 12 | [SID125305911] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 13 | [SID125305911] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 14 | [SID125305911] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) [AID652067, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) | | AID | 652067 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 15 | [SID125305911] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 16 | [SID125305911] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 17 | [SID125305911] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 18 | [SID125305911] | Inactive | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 19 | [SID125305911] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 20 | [SID125305911] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 21 | [SID125305911] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 22 | [SID125305911] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 23 | [SID125305911] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 24 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 25 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 26 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 27 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 28 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 29 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 30 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 31 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 32 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 33 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 34 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 35 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 36 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 37 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 38 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 39 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 40 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 41 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 42 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 43 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 44 | [SID125305911] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 45 | [SID125305911] | Inactive | | | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651636, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651636 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 46 | [SID125305911] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 47 | [SID125305911] | Inactive | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 48 | [SID125305911] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 49 | [SID125305911] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 50 | [SID125305911] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 125305911 | | CID | 53383241 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|